EUVIMEDEUVIMED entdecken
Open Access

Relations of Artificial Intelligence Vascular Age With Cardiometabolic Disease Progression: The Framingham Heart Study

David J Hamel-Sellman iD, Brenton R Prescott iD, Timothy J Korzinski iD, Vanessa Xanthakis iD, Leroy L Cooper iD, Naomi M Hamburg iD, Connie W Tsao iD, Emelia J Benjamin iD, Ramachandran S Vasan iD, Gary F Mitchell iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.044872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von David J Hamel-Sellman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Engineering, Inc. Needham MA USA. Hauptthemen laut MEDLINE: Vascular Stiffness, Artificial Intelligence, Cardiovascular Diseases. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aortic stiffening increases pulsatile power transmission into the microvasculature, resulting in blunted microvascular reactivity, which can impair postprandial nutrient processing and glucose homeostasis. Cardiometabolic disease (CMD) contributes to aortic stiffening and risk for major cardiovascular disease events. Our goal was to assess potential bidirectional relations of aortic stiffness with CMD progression.

Methods

Relations of artificial intelligence vascular age (AI‐VA), a measure of aortic stiffness, with new‐onset hypertension, diabetes, obesity, and lipid abnormalities were assessed in 7188 Framingham Heart Study (FHS) participants by using Cox proportional hazards regression. Short‐term bidirectional relations of AI‐VA with key continuous cardiometabolic measures were assessed by using autoregressive cross‐lagged panel models at 2 visits 6 years apart. Progression to CMD and cardiovascular disease states was visualized using multistate transition analysis.

Results

In models adjusted for standard vascular risk factors, accelerated AI‐VA was associated with elevated risk for incident hypertension (hazard ratio [HR], 1.44 [95% CI, 1.24–1.61]), diabetes (HR 1.29 [95% CI, 1.07–1.56]), lipid abnormalities (HR 1.13 [95% CI, 1.00–1.28]), and obesity (HR 1.23 [95% CI, 1.06–1.42]). Autoregressive cross‐lagged panel models demonstrated bidirectional relations between AI‐VA and fasting blood glucose, triglycerides, and mean arterial pressure consistent with a self‐reinforcing cycle of CMD progression. Multistate transition analysis demonstrated that most cardiovascular disease events (70%) occurred in participants who had developed at least 2 CMD states.

Conclusions

In our community‐based sample with repeated measures, AI‐VA, a measure of aortic stiffness, had bidirectional relations with continuous cardiometabolic measures and incident CMD, highlighting the potential utility of AI‐VA as a novel screening tool for CMD risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular StiffnessArtificial IntelligenceCardiovascular DiseasesHumansMaleFemaleMiddle AgedDisease ProgressionAdultRisk AssessmentMassachusettsAgedCardiometabolic Risk FactorsHypertension

Stichwörter der Autor:innen

aortic stiffnessartificial intelligencecardiometabolic risk factorscarotid‐femoral pulse wave velocity

Autor:innen und Institutionen

  • Cardiovascular Engineering, Inc. Needham MA USA.
  • Section of Preventive Medicine and Epidemiology, Department of Medicine Boston University Chobanian & Avedisian School of Medicine Boston MA USA.
  • Boston University and NHLBI's Framingham Study Framingham MA USA.
  • Department of Biostatistics Boston University School of Public Heath Boston MA USA.
  • Biology Department Vassar College Poughkeepsie NY USA.
  • Evans Department of Medicine Boston Medical Center Boston MA USA.

ORCID-Profile: David J Hamel-Sellman, Brenton R Prescott, Timothy J Korzinski, Vanessa Xanthakis, Leroy L Cooper, Naomi M Hamburg, Connie W Tsao, Emelia J Benjamin, Ramachandran S Vasan, Gary F Mitchell

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Hamel-Sellman, D. J., Prescott, B. R., Korzinski, T. J., Xanthakis, V., Cooper, L. L., Hamburg, N. M., Tsao, C. W., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2025). Relations of Artificial Intelligence Vascular Age With Cardiometabolic Disease Progression: The Framingham Heart Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044872

Vancouver

Hamel-Sellman DJ, Prescott BR, Korzinski TJ, Xanthakis V, Cooper LL, Hamburg NM, et al. Relations of Artificial Intelligence Vascular Age With Cardiometabolic Disease Progression: The Framingham Heart Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.044872

BibTeX
@article{HamelSellman2025,
  author = {Hamel-Sellman, David J and Prescott, Brenton R and Korzinski, Timothy J and Xanthakis, Vanessa and Cooper, Leroy L and Hamburg, Naomi M and Tsao, Connie W and Benjamin, Emelia J and Vasan, Ramachandran S and Mitchell, Gary F},
  title = {Relations of Artificial Intelligence Vascular Age With Cardiometabolic Disease Progression: The Framingham Heart Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.044872}
}
Kostenlos starten →